Holen Sie sich die Stockscreener-App
14.93
0.33%
-0.05
Handel nachbörslich:
14.99
0.06
+0.40%
Schlusskurs vom Vortag:
$14.98
Offen:
$15.14
24-Stunden-Volumen:
12.39M
Relative Volume:
0.53
Marktkapitalisierung:
$3.27B
Einnahmen:
$8.22B
Nettoeinkommen (Verlust:
$28.95M
KGV:
-248.83
EPS:
-0.06
Netto-Cashflow:
$901.06M
1W Leistung:
+4.11%
1M Leistung:
+3.82%
6M Leistung:
+14.32%
1J Leistung:
-18.33%
1-Tages-Spanne:
$14.93
$15.37
1-Wochen-Bereich:
$14.38
$16.26
52-Wochen-Spanne:
$11.20
$23.79
Oscar Health Inc Stock (OSCR) Company Profile
Firmenname
Oscar Health Inc
Sektor
Branche
Telefon
(646) 403-3677
Adresse
75 VARICK STREET, NEW YORK
Vergleichen Sie OSCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OSCR
Oscar Health Inc
|
14.93 | 4.04B | 8.22B | 28.95M | 901.06M | -0.06 |
|
UNH
Unitedhealth Group Inc
|
271.81 | 228.94B | 422.82B | 21.30B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
65.90 | 82.29B | 386.64B | 4.53B | 4.78B | 3.58 |
|
CI
Cigna Group
|
287.10 | 73.95B | 260.93B | 5.02B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
294.43 | 65.48B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
281.99 | 32.07B | 117.76B | 1.21B | 2.39B | 9.95 |
Oscar Health Inc Stock (OSCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-25 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-07-15 | Herabstufung | UBS | Neutral → Sell |
| 2025-07-14 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-07-11 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2025-07-02 | Eingeleitet | Barclays | Underweight |
| 2025-06-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-10 | Eingeleitet | Jefferies | Underperform |
| 2024-11-06 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-07 | Eingeleitet | UBS | Neutral |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-05-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-22 | Eingeleitet | Raymond James | Outperform |
| 2023-11-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-06-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-11-16 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-11-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-06-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-14 | Herabstufung | Goldman | Neutral → Sell |
| 2022-01-06 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-12-14 | Eingeleitet | Goldman | Sell |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-03-30 | Eingeleitet | Wells Fargo | Overweight |
| 2021-03-29 | Eingeleitet | BofA Securities | Buy |
| 2021-03-29 | Eingeleitet | Cowen | Market Perform |
| 2021-03-29 | Eingeleitet | Credit Suisse | Outperform |
| 2021-03-29 | Eingeleitet | Goldman | Buy |
| 2021-03-29 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Oscar Health Inc Aktie (OSCR) Neueste Nachrichten
Piper Sandler lowers Oscar Health stock price target to $13 on mixed results - Investing.com UK
Oscar Health, Inc. (OSCR) Reports Q2 Loss, Misses Revenue Estimates - MSN
The Top 5 Analyst Questions From Oscar Health’s Q2 Earnings Call - Yahoo Finance
19,524 Shares in Oscar Health, Inc. (NYSE:OSCR) Acquired by WealthPlan Investment Management LLC - MarketBeat
OSCR Q2 Deep Dive: Market Morbidity Pressures Offset by Strategic Cost Actions and Product Expansion - Yahoo Finance
Oscar Health (NYSE:OSCR) Downgraded by Wall Street Zen to Sell - MarketBeat
Oscar Health’s 336th-Ranked $310M Volume Hides 29% Revenue Surge and Widening Losses - AInvest
Oscar Health Second Quarter 2025 Earnings: Revenues Disappoint - Yahoo Finance
Oscar Health, Inc. (NYSE:OSCR) Q2 2025 Earnings Call Transcript - MSN
Oscar Health Reports Q2 2025 Revenue Growth Amid Losses - TipRanks
Oscar Health Inc. stock trendline breakdownSmart Safety Strategy With Real Data Analysis - Newser
Oscar Health, Inc. (NYSE:OSCR) Short Interest Up 118.5% in July - MarketBeat
Will Oscar Health Inc. be affected by tariffsVolatility Breakout Trade Watch - thegnnews.com
XTX Topco Ltd Makes New Investment in Oscar Health, Inc. (NYSE:OSCR) - MarketBeat
Oscar Health Rises Amid Dropped Volume as 392nd in Market Activity Amid Mixed Earnings and 2026 Profit Target - AInvest
Using data filters to optimize entry into Oscar Health Inc.Daily Exit and Entry Price Prediction - Newser
Oscar Health shares decline after missing Q2 forecasts - MSN
Wall Street Got Oscar All Wrong (NYSE:OSCR) - Seeking Alpha
Here's Why I Am Buying More Shares of Oscar Health After Earnings - The Motley Fool
Oscar Health’s Earnings Call: Growth Amid Challenges - TipRanks
Oscar Health Surges 5.72% Despite Q2 Net Loss as $380M Volume Ranks 304th in Daily Liquidity - AInvest
BIT Capital GmbH Buys 47,592 Shares of Oscar Health, Inc. (NYSE:OSCR) - MarketBeat
Oscar Health’s ICHRA push continues - Endpoints News
Cautious Outlook: Oscar Health’s Financial Challenges and Sell Recommendation Amid Industry Uncertainties - TipRanks
Oscar Health remains bullish on recovery amid insurance industry turmoil - Crain's New York Business
Oscar Health (OSCR) Reports US$228 Million Q2 Loss After Last Year's Profit - Yahoo Finance
Oscar Health's ICHRA Gambit: Navigating Regulatory Flexibility to Unlock $12 Billion in 2025 Growth - AInvest
JPMorgan Chase & Co. Reduces Stake in Oscar Health Inc. - GuruFocus
Oscar Health outlines $12B–$12.2B 2025 revenue target and new ICHRA strategy amid market reset - MSN
Oscar Health slips after earnings miss - Sherwood News
Oscar Health's Q2 2025: Key Contradictions in Risk Adjustments, Membership Trends, and Market Positioning - AInvest
Oscar Health's 3.76% Surge Defies 289th Trading Rank Amid 29% Revenue Jump and 2026 Profit Push - AInvest
Oscar Health’s Projections and Market Implications - StocksToTrade
Oscar Health Stock Surge: Buying Opportunity? - timothysykes.com
Oscar Health losses, Match Group outlook, Angi stock surges - Yahoo Finance
Oscar Health Well-Positioned To Manage Market Reset, Eyes Profitability In 2026 - Yahoo Finance
Oscar Health (NYSE:OSCR) Misses Q2 Sales Targets - Yahoo Finance
Oscar Health shares rise 2.71% intraday after reporting Q2 earnings and reaffirming FY guidance. - AInvest
Earnings call transcript: Oscar Health Q2 2025 earnings miss forecasts By Investing.com - Investing.com South Africa
Earnings call transcript: Oscar Health Q2 2025 earnings miss forecasts - Investing.com
Oscar Health Swings to Loss as Forecast, Expects Return to Profitability in 2026 - The Wall Street Journal
Oscar Health's Q2 2025 Earnings: A Pivotal Moment for Long-Term Healthcare Tech Growth? - AInvest
Oscar Health reports Q2 EPS (89c), consensus (84c) - TipRanks
Oscar Health Reports Q2 GAAP EPS of -$0.89, Revenue of $2.86B Misses Expectations - AInvest
Oscar Health Announces Financial Results for Second Quarter 2025 - TradingView
Oscar Health earnings missed by $0.05, revenue fell short of estimates - Investing.com Australia
Oscar Health shares fall after missing second quarter expectations By Investing.com - Investing.com Nigeria
Oscar Health shares fall after missing second quarter expectations - Investing.com
Oscar Health misses Q2 revenue estimates, reaffirms FY guidance - MarketScreener
Earnings Flash (OSCR) Oscar Health Posts Q2 Loss $0.89 a Share, vs. FactSet Est of $0.81 Loss - MarketScreener
Oscar Health Announces Financial Results for Second Quarter 2025 and Reaffirms Updated 2025 Guidance - Business Wire
Finanzdaten der Oscar Health Inc-Aktie (OSCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):